LGX 818 25mg
LGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.
| Trivial name | LGX 818 25mg |
| Catalog Number | A13226-25 |
| Alternative Name(s) | (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate |
| Molecular Formula | C22H27ClFN7O4S |
| CAS# | 1269440-17-6, 1269440-29-0 |
| SMILES | C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=CC(=CC(=C3F)NS(=O)(=O)C)Cl)C(C)C)NC(=O)OC |
| Size | 25mg |
| Supplier Page | http://www.adooq.com/lgx-818.html |